Smithsonian Magazine · People & society

The Rise of Peptides: From Niche to Mainstream

Peptides, short amino acid chains, are gaining popularity for purported benefits like weight loss and anti-aging. However, many are experimental, lack FDA approval, and carry safety concerns.

Peptides, once niche, are now widely marketed online for health and aesthetic improvements, fueled by demand for self-optimization and dissatisfaction with healthcare.

Many available peptides are unapproved experimental chemicals, untested and unregulated, with no FDA assurance of identity or purity.

Despite risks, peptides have a following, with nearly half of physicians reporting patients using them. Social media showcases transformations and peptide combinations.

The trend reflects a shift to a consumer-driven market, creating a "parallel health system" based on self-diagnosis and easy online access.

Historically, peptides like insulin were vital. Recent decades saw bodybuilders self-experimenting. GLP-1 drugs for weight loss boosted consumer visibility and normalized online purchases.

This trend taps into a desire for quick fixes, with salespeople filling demand. Peptides appeal to those distrusting authority, seeking control over cellular processes.

The pandemic accelerated DIY medicine and online healthcare. Declining trust in authorities fosters "do your own research" medicine, with unknown long-term risks.

AI-samenvatting op basis van de bron.